Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OXU-001 by Oxular for Diabetic Macular Edema: Likelihood of Approval
OXU-001 is under clinical development by Oxular and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase...